RTN4RL2 (NM_178570) Human Untagged Clone

SKU
SC310413
RTN4RL2 (untagged)-Human reticulon 4 receptor-like 2 (RTN4RL2)
  $457.00
In Stock*
Specifications
Specifications
Product Data
Type Human Untagged Clone
Target Symbol RTN4RL2
Synonyms NgR2; NGRH1
Vector pCMV6-Entry
E. coli Selection Kanamycin (25 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
Fully Sequenced ORF
>SC310413 representing NM_178570.
Blue=Insert sequence Red=Cloning site Green=Tag(s)

GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG
GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC
ATGCTGCCCGGGCTCAGGCGCCTGCTGCAAGCTCCCGCCTCGGCCTGCCTCCTGCTGATGCTCCTGGCC
CTGCCCCTGGCGGCCCCCAGCTGCCCCATGCTCTGCACCTGCTACTCATCCCCGCCCACCGTGAGCTGC
CAGGCCAACAACTTCTCCTCTGTGCCGCTGTCCCTGCCACCCAGCACTCAGCGACTCTTCCTGCAGAAC
AACCTCATCCGCACGCTGCGGCCAGGCACCTTTGGGTCCAACCTGCTCACCCTGTGGCTCTTCTCCAAC
AACCTCTCCACCATCTACCCGGGCACTTTCCGCCACTTGCAAGCCCTGGAGGAGCTGGACCTCGGTGAC
AACCGGCACCTGCGCTCGCTGGAGCCCGACACCTTCCAGGGCCTGGAGCGGCTGCAGTCGCTGCATTTG
TACCGCTGCCAGCTCAGCAGCCTGCCCGGCAACATCTTCCGAGGCCTGGTCAGCCTGCAGTACCTCTAC
CTCCAGGAGAACAGCCTGCTCCACCTACAGGATGACTTGTTCGCGGACCTGGCCAACCTGAGCCACCTC
TTCCTCCACGGGAACCGCCTGCGGCTGCTCACAGAGCACGTGTTTCGCGGCCTGGGCAGCCTGGACCGG
CTGCTGCTGCACGGGAACCGGCTGCAGGGCGTGCACCGCGCGGCCTTCCGCGGCCTCAGCCGCCTCACC
ATCCTCTACCTGTTCAACAACAGCCTGGCCTCGCTGCCCGGCGAGGCGCTCGCCGACCTGCCCTCGCTC
GAGTTCCTGCGGCTCAACGCTAACCCCTGGGCGTGCGACTGCCGCGCGCGGCCGCTCTGGGCCTGGTTC
CAGCGCGCGCGCGTGTCCAGCTCCGACGTGACCTGCGCCACCCCCCCGGAGCGCCAGGGCCGAGACCTG
CGCGCGCTCCGCGAGGCCGACTTCCAGGCGTGTCCGCCCGCGGCACCCACGCGGCCGGGCAGCCGCGCC
CGCGGCAACAGCTCCTCCAACCACCTGTACGGGGTGGCCGAGGCCGGGGCGCCCCCAGCCGATCCCTCC
ACCCTCTACCGAGATCTGCCTGCCGAAGACTCGCGGGGGCGCCAGGGCGGGGACGCGCCTACTGAGGAC
GACTACTGGGGGGGCTACGGGGGTGAGGACCAGCGAGGGGAGCAGATGTGCCCCGGCGCTGCCTGCCAG
GCGCCCCCGGACTCCCGAGGCCCTGCGCTCTCGGCCGGGCTCCCCAGCCCTCTGCTTTGCCTCCTGCTC
CTGGTGCCCCACCACCTCTGA

ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGAT
TACAAGGATGACGACGATAAG
GTTTAAACGGCCGGC
Restriction Sites SgfI-MluI |
ACCN NM_178570
Insert Size 1263 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution Method 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Note Plasmids are not sterile.  For experiments where strict sterility is required, filtration with 0.22um filter is required.
Shipping Ambient
Reference Data
RefSeq NM_178570.2
RefSeq Size 2220 bp
RefSeq ORF 1263 bp
Locus ID 349667
UniProt ID Q86UN3
Cytogenetics 11q12.1
Protein Families Druggable Genome
MW 46.1 kDa
Summary Cell surface receptor that plays a functionally redundant role in the inhibition of neurite outgrowth mediated by MAG (By similarity). Plays a functionally redundant role in postnatal brain development. Contributes to normal axon migration across the brain midline and normal formation of the corpus callosum. Does not seem to play a significant role in regulating axon regeneration in the adult central nervous system. Protects motoneurons against apoptosis; protection against apoptosis is probably mediated by MAG (By similarity). Like other family members, plays a role in restricting the number dendritic spines and the number of synapses that are formed during brain development (PubMed:22325200). Signaling mediates activation of Rho and downstream reorganization of the actin cytoskeleton (PubMed:22325200).UniProtKB/Swiss-Prot Function
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources
"NM_178570" in other vectors (6)
SKU Description Size Price
RC217072 RTN4RL2 (Myc-DDK-tagged)-Human reticulon 4 receptor-like 2 (RTN4RL2) 10 ug
$289.00 $457.00
RC217072L1 Lenti ORF clone of Human reticulon 4 receptor-like 2 (RTN4RL2), Myc-DDK-tagged 10 ug
$757.00
RC217072L2 Lenti ORF clone of Human reticulon 4 receptor-like 2 (RTN4RL2), mGFP tagged 10 ug
$757.00
RC217072L3 Lenti ORF clone of Human reticulon 4 receptor-like 2 (RTN4RL2), Myc-DDK-tagged 10 ug
$757.00
RC217072L4 Lenti ORF clone of Human reticulon 4 receptor-like 2 (RTN4RL2), mGFP tagged 10 ug
$757.00
RG217072 RTN4RL2 (tGFP-tagged) - Human reticulon 4 receptor-like 2 (RTN4RL2) 10 ug
$489.00 $657.00

file-alt Citations

A novel sialylation pathway mediated by extracellular vesicles in aggressive prostate cancer
Bach, Hossain, Chaudhari et al
PLoS One (2025) 20 (9), e0329014 DOI: 10.1371/journal.pone.0329014
Cited by 4
AI Summary: OriGene products contributed to this study by providing the RTN4RL2 cDNA vector (SC310413) for Nogo-66 receptor homolog 2 (NgR2) expression and the empty vector control (PS100001), which were used to generate NgR2 and mock transfectant DU145 prostate cancer cells for functional analyses of extracellular vesicle-mediated sialylation.
Snippet: DU145 cells were transfected with a vector carrying RTN4RL2 cDNA, encoding for Nogo-66 receptor homolog 2 (NgR2) or an empty vector (Origene, SC310413 and PS100001, respectively), named as NgR2 transfectants or Mock DU145 cells, as previously described [28]. …
FigureFigureFigure
Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro-tumorigenic activity in vivo through a GPI-anchored receptor, NgR2
Verrillo, Quaglia, Shields et al
J Extracell Vesicles (2024) 13 (8), e12482 DOI: 10.1002/jev2.12482
Cited by 8
AI Summary: In this study, OriGene's pCMV6-Entry vector carrying RTN4RL2 (SC310413) and the empty vector (PS100001) were used to generate DU145 prostate cancer cell lines overexpressing NgR2 or as controls, enabling the authors to investigate the role of NgR2 in sEV cargo composition and pro-tumorigenic activity.
Snippet: Dharmacon/Horizon, VSC11707) and were selected using 2 μg/mL puromycin, as previously described (Quaglia et al., 2022). DU145 cells were transfected with a pCMV6‐Entry vector carrying RTN4RL2 (Origene, SC310413) or an empty vector (Origene, PS100001), designated as NgR2‐DU145 or Mock‐DU145 cells, as previously described (Quaglia et al., 2022). Briefly, cells were plated at 5 × 105 
FigureFigureFigure
Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer
Testa, Quaglia, Naranjo et al
Matrix Biol (2023) 124, 49-62 DOI: 10.1016/j.matbio.2023.11.003
Cited by 12
AI Summary: OriGene products pCMV6-Entry vector carrying RTN4RL2 (SC310413) and the empty vector (PS100001) were used to generate DU145 prostate cancer cell lines overexpressing NgR2 and control cells, enabling the study of NgR2's role in neuroendocrine prostate cancer progression.
Snippet: …DU145 cells were transfected with pCMV6-Entry vector carrying RTN4RL2 (DU145 NgR2 cells) (Origene, SC310413) or an empty vector (DU145 Mock cells) (Origene, PS100001) as previously described [34]. …DU145 cells were transfected with pCMV6-Entry vector carrying RTN4RL2 (DU145 NgR2 cells) (Origene, SC310413) or an empty vector (DU145 Mock cells) (Origene, PS100001) as previously described [34]
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer
Quaglia, Krishn, Sossey-Alaoui et al
Sci Rep (2022) 12 (1), 18879 DOI: 10.1038/s41598-022-21711-5
Cited by 6
AI Summary: OriGene products pCMV6-Entry vector carrying RTN4RL2 (SC310413) and the empty vector control (PS100001) were used to transfect DU145 prostate cancer cells, enabling the study of NgR2’s role in neuroendocrine differentiation and cell behavior.
Snippet: a control, PC3 cells were transfected with a non-targeting scrambled control shRNA (SMARTvector, Dharmacon/Horizon, VSC11707). DU145 cells were transfected with pCMV6-Entry vector carrying RTN4RL2 (Origene, SC310413) or with the empty vector as a control (Origene, PS100001). … The next day, cells were washed with;- DU145 cells were transfected with pCMV6-Entry vector carrying RTN4RL2 (Origene, SC310413) or with the empty vector as a control (Origene, PS100001). …
FigureFigureFigure
Showing 1-4 of 4 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products